Results 11 to 20 of about 101,135 (306)

Impact of anticoagulation and antiplatelet therapy on dialysis catheter fibrin sheath formation [PDF]

, 2022
PURPOSEFibrin sheaths are a significant cause of dialysis catheter dysfunction. This study aimed to determine the role of anticoagulation, antiplatelet medications, and other factors in delaying fibrin sheath formation.METHODSAn institutional review ...
Forrest B. Linch, Mauricio F. Jin, Richard G. Frimpong, Scott M. Thompson, Christopher J. Reisenauer, Edwin A. Takahashi   +5 more
core   +1 more source

Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention [PDF]

, 2020
Complex percutaneous coronary intervention (PCI) patients are a high-risk population for ischemic complications. Antiplatelet therapy in such patients remains controversial, as the beneficial effects of more potent agents use or prolonged dual ...
Dimitrios Alexopoulos, Charalampos Varlamos, Despoina-Rafailia Benetou   +2 more
core   +1 more source

Pharmacogenetics of Antiplatelet Therapy

Annual Review of Pharmacology and Toxicology, 2023
Antiplatelet therapy is used in the treatment of patients with acute coronary syndromes, stroke, and those undergoing percutaneous coronary intervention. Clopidogrel is the most widely used antiplatelet P2Y12 inhibitor in clinical practice. Genetic variation in CYP2C19 may influence its enzymatic activity, resulting in individuals who are carriers of ...
Matteo, Castrichini, Jasmine A, Luzum, Naveen, Pereira   +2 more
openaire   +2 more sources

Oesophageal submucosal hematoma after flow diverter embolization with favourable outcome treated by discontinuing postoperative antiplatelet therapy for only three days: a case report

JA Clinical Reports, 2019
Background Oesophageal submucosal hematoma is a rare perioperative complication. When this complication develops after endovascular surgery, which requires postoperative antiplatelet therapy, whether to stop antiplatelet therapy or not is controversial ...
Eriko Takeyama, Aiko Wada, Eizo Amano, Hiromi Shibuya   +3 more
doaj   +1 more source

The Risk of Perioperative Bleeding in Patients with Dual Antiplatelet Therapy

Український журнал серцево-судинної хірургії, 2021
Background. Patients with dual antiplatelet therapy have high risk of perioperative bleeding. In this article we evaluated the risk of bleeding in patients whose antiplatelet therapy had not been canceled before coronary artery bypass grafting (CABG).
Taras M. Domanskyy, Artur V. Gabriyelyan, Oleg V. Beregovoy, Stanislav I. Filianin, Svitlana S. Moshta   +4 more
doaj   +1 more source

Personalized Antiplatelet Therapy Following Endovascular Revascularization in Peripheral Artery Occlusive Disease: A Novel Concept

EJVES Short Reports, 2015
: Case: A 73 year old patient with a longstanding history of peripheral artery occlusive disease (PAOD) presented with an acute on chronic progression of symptoms, based on a long occlusion of the superficial femoral artery (SFA), which was treated by ...
S.M.O. Peeters Weem, T.C. Leunissen, M. Teraa, E.J. Vonken, G.J. de Borst, F.L. Moll   +5 more
doaj   +1 more source

Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II trials [PDF]

, 2009
<p><b>Background and Purpose:</b> A number of factors have been associated with postthrombolysis intracerebral hemorrhage, but these have varied across studies.</p> <p><b>Methods:</b> We examined patients with
Demchuk, A., Lees, K.R., Kasner, S.E., Messe, S.R., Cucchiara, B., Levine, S.R., Lyden, P., Sansing, L., Tanne, D.   +8 more
core   +1 more source

Dual Antiplatelet Therapy in Patients With Minor Stroke Receiving Intravenous Thrombolysis

Frontiers in Neurology, 2022
IntroductionConcern over the potential severe bleeding risk of dual antiplatelet therapy for patients with minor stroke after intravenous thrombolysis (IVT) leads to different antiplatelet strategies in the secondary prevention of stroke.
Zhaohan Xu, Nihong Chen, Nihong Chen, Huiling Sun, Teng Jiang, Qiwen Deng, Junshan Zhou, Yingdong Zhang   +7 more
doaj   +1 more source

Drug resistance with monitored adherence [PDF]

, 2013
Drug resistance can be defined as the failure of a drug to exert its expected effect on pharmacological biomarkers and is caused by pharmacogenetic, cellular or clinical factors.
Walter, Philipp Niklaus
core   +1 more source

Outcomes of Severe Sepsis and Septic Shock Patients on Chronic Antiplatelet Treatment: A Historical Cohort Study

Critical Care Research and Practice, 2013
Background. Sepsis is characterized by dysfunctional activation of platelets, and antiplatelet therapy could improve the outcomes of septic patients. Methods.
Juan C. Valerio-Rojas, Insara J. Jaffer, Daryl J. Kor, Ognjen Gajic, Rodrigo Cartin-Ceba   +4 more
doaj   +1 more source